Head of Investor Relations
Ron Aldridge
Head of Investor Relations
Ptc Therapeutics, Inc. (PTCT)Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.
About Ron Aldridge
Ron Aldridge is recorded as Head of Investor Relations at Ptc Therapeutics, Inc. (PTCT). Ron Aldridge has spoken on 2 earnings calls across 1 company, most recently for Ptc Therapeutics, Inc. on August 8, 2024.
Summary generated from SEC filings and earnings-call records held by Equibles.
Affiliation history
Recorded current and former roles; source labels appear when available.
-
Current
Company network
Recorded roles and call appearances connecting this person to public companies.
Leadership on record at Ptc Therapeutics, Inc.
Other people whose current roles at this company are on record from its filings.
- Dr. Matthew B. Klein CEO, Board Member
- Matthew B. Klein CEO
- Matthew Klein CEO, Board Member
- Michael Schmertzler CFO
- Mark E. Boulding General Counsel
- Christine Utter Chief Accounting Officer
- Allan Jacobson Board Member
- David P. Southwell Board Member
- Hege Sollie-Zetlmayer Board Member
- Jessica Chutter Board Member
Recent activity
Earnings-call and investor-event appearances, plus filed executive appointments or departures, newest first.